Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Petrelintide

ZUPREME

Roche · Phase 2 · Completed · Enrollment 493

NCT06662539

EudraCT 2024-512549-18

ArmPopulationDoseWeeksEstimandWeight change
Petrelintide Dose 1Obesity or overweightn/rn/rn/rn/r
Petrelintide Dose 2Obesity or overweightn/rn/rn/rn/r
Petrelintide Dose 3Obesity or overweightn/rn/rn/rn/r
Petrelintide Dose 4Obesity or overweightn/rn/rn/rn/r
Petrelintide Dose 5Obesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r